LISATA THERAPEUTICS, INC. (LSTA) Free cash flow 2015–2024
LISATA THERAPEUTICS, INC. (LSTA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$16.0MFY2024 · since FY2015: -$24.8M → -$16.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$16.0M | +17.5% |
| FY2023 | -$19.4M | +3.4% |
| FY2022 | -$20.0M | +6.6% |
| FY2021 | -$21.5M | +3.8% |
| FY2020 | -$22.3M | -152.2% |
| FY2019 | -$8.8M | +53.2% |
| FY2018 | -$18.9M | +6.2% |
| FY2017 | -$20.1M | +4.2% |
| FY2016 | -$21.0M | +15.2% |
| FY2015 | -$24.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice